Efficacy And Safety Of CX516 In Elderly Participants With Mild Cognitive Impairment.

NCT00040443 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

175

Enrollment

INDUSTRY

Sponsor class

Conditions

Mild Cognitive Impairment

Interventions

DRUG: CX516
DRUG: Placebo

Sponsor

RespireRx